Pfizer in deal for Philogen's Dekavil

Philogen S.p.A (Siena, Italy) granted Pfizer Inc. (NYSE:PFE) a worldwide license to Philogen's Dekavil, an immunocytokine consisting of a vascular targeting antibody fused to the anti-inflammatory cyt...